A Scotland-based company, 1nhaler, has secured £2.2 million to move its pop-up cardboard inhaler toward clinical trials and its first regulatory approval. The funding is aimed at progressing the device’s development and bringing it closer to potential use as a drug delivery option.
Across the two reports, both outlets emphasize the same core milestone: the company’s follow-on funding and the planned next steps toward regulatory approval. The Herald Scotland frames the story around the fundraising amount and the “key milestone” nearing, while Tech.eu highlights the device’s purpose of replacing bulky plastic inhalers with a cardboard alternative. Neither report provides additional detail on clinical trial design, specific regulators, or timelines beyond the stated path to approvals.
